Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer

被引:155
作者
Kusmartsev, Sergei [1 ]
Gabrilovich, Dmitry I. [1 ]
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA
关键词
tumor immunology; immune suppression; cytokines; growth factors; myeloid cells;
D O I
10.1007/s10555-006-9002-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is well established that cancers affect differentiation of dendritic cells and promote systemic expansion of immune suppressive immature myeloid cells. This phenomenon may represent a mechanism of tumor escape from immune attack and could have significant impact on tumor progression. In this review we discuss the role of different tumor-derived factors, which were implicated in abnormal myeloid cell differentiation. The role of reactive oxygen species as well as JAK/STAT signaling in mechanisms of the effects of tumor-derived factors on myeloid cells is also discussed.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 70 条
[1]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[2]  
2-4
[3]  
ALLEVA DG, 1995, J LEUKOCYTE BIOL, V57, P919
[4]  
Almand B, 2000, CLIN CANCER RES, V6, P1755
[5]   Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer [J].
Almand, B ;
Clark, JI ;
Nikitina, E ;
van Beynen, J ;
English, NR ;
Knight, SC ;
Carbone, DP ;
Gabrilovich, DI .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :678-689
[6]  
BEISSERT S, 1995, J IMMUNOL, V154, P1280
[7]  
Berman RM, 1996, J IMMUNOL, V157, P231
[8]   Role of tumor-associated gangliosides in cancer progression [J].
Birklé, S ;
Zeng, G ;
Gao, L ;
Yu, RK ;
Aubry, J .
BIOCHIMIE, 2003, 85 (3-4) :455-463
[9]   Identification of a CD11b+/Gr-1+/CD31+ myeloid progenitor capable of activating or suppressing CD8+ T cells [J].
Bronte, V ;
Apolloni, E ;
Cabrelle, A ;
Ronca, R ;
Serafini, P ;
Zamboni, P ;
Restifo, NP ;
Zanovello, P .
BLOOD, 2000, 96 (12) :3838-3846
[10]  
Bronte V, 1999, J IMMUNOL, V162, P5728